Periodic Reporting for period 2 - MAESTRO (Magneto-Acoustically Engineered Steerable Robots)
Periodo di rendicontazione: 2022-08-01 al 2024-01-31
WP1: Personalized model and pre-operative plan
Accurate targeting during robotic probe insertion requires a reliable and stable model representing geometry and dynamics of both the probe and its environment. These models are used to generate adequate algorithms for pre-operative planning and intra-operative control of the intervention. The objective of WP1 is to develop a personalized (patient-specific) route-map and model for pre-operative planning that predicts the path of the probe with the actuated segments.
WP2: Intra-operative control of the flexible probe
The pre-operative plan is in essence the roadmap, and provides an initial track for the flexible probe at the commencement of the intervention to reach its target. However, diversions in the probe path/target coordinates due to unmodeled perturbations have to be factored-in by developing necessary intra-operative control schemes. The objective of WP2 is to develop a robust intra-operative controller for the probe steering system operating in uncertain environments.
WP3: Robotic system for steering the flexible probe
MAESTRO will use techniques from mechanisms theory and soft robotics to design a novel probe with built‑in sensing capabilities. The multi-segmented flexible probe will be merged with innovative control strategies, and US- and FBG-based servoing to reshape the probe segments while steering it to a target. The objective of WP3 is to create, integrate, and evaluate the pre-operative plans and intra-operative control techniques to steer the magnetically-actuated probe in the proximity of the desired target.
WP4: Tracking and control of the micro-agents
The probe steering system will transport the micro-agents in close vicinity of the desired target. These agents have the potential to perform localized and personalized diagnosis and therapy. The objective of WP4 is to perform US- and fluorescence-guided tracking, and magneto-acoustic control of micro-agents using an electromagnetic- and piezoelectric-driven microrobotic system.
Innovations (WP1): 1. Multi-scale model will describe the evolving shape of a probe surrounded by tissue and is applicable to other continuum-style (flexible) robots used within the context of MIS. 2. Fluorescence images coupled with US data will provide unprecedented insights for visualization of the pre-operative path, and used for both the flexible probe and micro-agents.
Innovations (WP2) : 1. Techniques will be developed to track the flexible probe using US images and FBG sensors. 2. Robust model predictive controller (RMPC) with pre-operative plans can control the flexible probe in the presence of various disturbances (while compensating for organ motion).
Innovations (WP3) : 1. Enhanced probe insertion system that includes the multi-segmented probe with soft and compliant microstructure will allow unlimited steerability and actuation functionalities. 2. Electromagnetic system will be capable of applying controlled fields/gradients, and the optimized coil configuration will have an enlarged workspace, fast response time, and high actuation bandwidth. 3. Modular design will permit both image-guided control and human-guided control, which will enable insertion and navigation of surgical instruments via the working channel of the MAESTRO probe.
Innovations (WP4): 1. Stable 3D visual tracking algorithms will track microrobots and clusters
of nanoparticles. 2. Nonlinear disturbance observer architecture will account for modeling and environmental uncertainties, while estimating interaction forces that are useful in microassembly tasks. 3. Use of 3D photolithography for monolithic fabrication provides convenient means of rapid prototyping micro-agents with dexterity over design. 4. Focused electrodeposition provides a plethora of alternatives for material selection to functionalize the agents as magneto-acoustic microrobots. 5. Prototype enables magnetic steering and acoustic release of drug loaded bio-hybrid micro-agents (e.g. doxorubicin) for personalized diagnosis.